Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Status:
Completed

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

This study will assess the efficacy and safety of BGG492 as adjunctive treatment in patients with partial onset seizures.

Phase 2

Novartis